Patents for C12P 21 - Preparation of peptides or proteins (112,499)
07/2007
07/04/2007EP1257658B1 Method for increasing the gene expression of transfected genes
07/04/2007EP1242823B1 Selecting library members capable of binding to epitopes
07/04/2007EP1121382B9 Interferon-beta fusion proteins and uses
07/04/2007EP1100811B1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
07/04/2007EP0948542B1 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
07/04/2007EP0868435B1 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein
07/04/2007EP0567566B2 Methods for treating tumor necrosis factor mediated diseases
07/04/2007CN1993475A Methods for transforming and expression screening of filamentous fungal cells with a DNA library
07/04/2007CN1993469A Recombinant alpha-fetoprotein, method and means for preparation thereof, compositions on the base thereof and use thereof
07/04/2007CN1993463A Follistatin mutant polypeptide
07/04/2007CN1990875A Globin zymolyte and its preparation and application
07/04/2007CN1990870A Chicken infectivity bursa of Fabricius virus VP3 gene, expressed recombinant protein and application
07/04/2007CN1990869A Chicken infectivity bursa of Fabricius virus VP2 cDNA, its expression vector, expressed recombinant protein and application thereof
07/04/2007CN1990868A Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
07/04/2007CN1990866A Nucleic acid sequence, expression vector and application of wheat kernel texture coding gene
07/04/2007CN1990862A Production method of recombined human alpha1-thymus peptide and preparation thereof
07/04/2007CN1990504A Earthworm protein suppressing cancer cell accretion by road spectrum
07/04/2007CN1324143C Poly-gamma-glutamate having ultra high molecular weight and method for using the same
07/04/2007CN1324140C Preparation of biologically active molecules
07/04/2007CN1324139C Vaccines
07/04/2007CN1324138C Eukaryon expression of coli heat-sensitive toxin B subunit
07/04/2007CN1324049C Human source anti SARS coronavirus gene engineering antibody
07/03/2007US7238859 Ecdysone receptors and methods for their use
07/03/2007US7238799 Mustang, a gene and nuclear protein
07/03/2007US7238788 Selectively binds to a human tau epitope comprising a phosphorylated tyrosine residue corresponding to the tyrosine residue
07/03/2007US7238787 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
07/03/2007US7238785 Antibody binding to glycoprotein; therapy, diagnosis of cancer
07/03/2007US7238784 Hybrids for testing red blood cells for presence of one or more Rh factors; one-step agglutination
07/03/2007US7238782 Contacting cells, which contains binding proteins and cis-acting element of CD40 3'-untranslated region linked to nucleotide sequences that code for reporter molecules, with drugs or biological targets, then detecting gene expression of the coded reporter molecule in the cell; drug screening; analyzing
07/03/2007US7238780 G-protein coupled receptor
07/03/2007US7238667 Albumin fusion proteins
07/03/2007US7238657 Cartilage/Bone inducing materials for preparation
07/03/2007US7238516 Method of hydrolyzing jojoba protein
07/03/2007US7238515 Anti-Listeria bacteriocin
07/03/2007US7238514 Using trangenic yeast for producing terpenes; antiinflammatory agents
07/03/2007US7238513 Nucleic acid sequences encoding Conus protein disulfide isomerase
07/03/2007US7238510 Glycoprotein synthesis
07/03/2007US7238507 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
07/03/2007US7238502 Method for zymotic production of fine chemicals (metA) containing sulphur
07/03/2007US7238499 Trimeric macrophage scavenger receptor fusion proteins and encoding nucleic acids
07/03/2007US7238498 Screening methods
07/03/2007US7238497 Synthetic DNA encoding an orange seapen-derived green fluorescent protein with codon preference of mammalian expression systems and biosensors
07/03/2007US7238478 Compositions and methods for protein isolation
07/03/2007US7238360 Getting the same result as gene therapy, without the introduction of exogenous DNA, by binding T cell with immunomodulator biotin, then contacting with avidin or streptavidin; apoptosis induction or resistance
07/03/2007US7238356 Core-glycosylated HCV envelope proteins
07/03/2007US7238354 Method of treating atopic dermatitis using antibody against human interleukin-5 receptor alpha chain
07/03/2007US7238345 Nucleic acids and vectors; transformed host cells for expressing oligopeptides containing epitopes of use to immunize against meningococcal disease
07/03/2007CA2361987C Goodpasture antigen binding protein
07/03/2007CA2256413C Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy
07/03/2007CA2243302C Anti-human vegf receptor f1t-1 monoclonal antibody
07/03/2007CA2216611C Utrophin gene promoter
07/03/2007CA2166685C An enzyme with protease activity
07/03/2007CA2092567C Nt-4 neurotrophic factor
06/2007
06/28/2007WO2007072866A1 Anti-ilt7 antibody
06/28/2007WO2007072611A1 Dna inducing ovarian duct-specific gene expression
06/28/2007WO2007072576A1 Method for production of strain capable of expressing m toxin derived from helicobacter pylori in large quantity
06/28/2007WO2007071072A1 High-rate perfusion bioreactor
06/28/2007WO2007071068A1 Process for the production of preformed conjugates of albumin and a therapeutic agent
06/28/2007WO2007071062A1 Methods and compositions for the detection and isolation of ligands
06/28/2007WO2007071061A1 Methods for generating and screening fusion protein libraries and uses thereof
06/28/2007WO2007021297A9 COMPOSITIONS OF tRNA AND USES THEREOF
06/28/2007WO2007012004A3 Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
06/28/2007WO2007011698A3 Humanized antibody conjugates and related methods, assays, reagents, and kits
06/28/2007WO2006058225A8 Enzymatic reactions in the presence of keto acids
06/28/2007WO2006035439A3 Recombinant human t2 rnase and uses thereof
06/28/2007WO2005118831A3 Polymeric compositions and related methods of use
06/28/2007WO2005072419A3 Gastrointestinal proliferative factor and uses thereof
06/28/2007WO2003061562A8 Production of recombinant therapeutic bioscavengers against chemical and biological agents
06/28/2007US20070150984 Genetic sequences having methyltransferase activity and uses therefor
06/28/2007US20070150973 Genetically engineering cell to regulate expression of gene target via nucleic acid coding fusion protein having transcription regulatory domain and composite DNA binding domain; gene therapy
06/28/2007US20070149770 Poly zinc finger proteins with improved linkers
06/28/2007US20070149769 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
06/28/2007US20070149764 Polypeptide having collagen-like structure
06/28/2007US20070149565 Nelfinavir conjugates and antibodies useful in immunoassay
06/28/2007US20070149455 Modified and stabilized gdf propeptides and uses thereof
06/28/2007US20070149453 Treating inflammation using a biological agent that causes cells to release cytokine receptors
06/28/2007US20070149449 Therapeutic targets in cancer
06/28/2007US20070148774 Methods for producing members of specific binding pairs
06/28/2007US20070148765 Preservative-containing virus formulations
06/28/2007US20070148752 Polypeptide which can degrade galactose bonds; hybridization; useful in sugar chain engineering reagents and analyzing polysaccharide structure
06/28/2007US20070148748 Fermentation process using specific oxygen uptake rates as a process control
06/28/2007US20070148739 amino acid substitutions at specific positions that confer increased relative activity in biological assays with reduced immunogenic potential in the protein; hepatitis C virus infection
06/28/2007US20070148738 comprising bromodomain successfully isolated from a human testis cDNA library using primers prepared based on an EST sequence; for diagnosis and treatment of cancer
06/28/2007US20070148737 Materials and Methods For the Purification of Polyelectrolytes, Particularly Nucleic Acids
06/28/2007US20070148736 Diagnosis of human papilloma virus (HPV); using filter with a pore size greater than a dimension of a HPV particle but smaller than a dimension of a HPV infected cell
06/28/2007US20070148735 Novel chromophores/fluorophores and methods for using the same
06/28/2007US20070148734 Hyaluronic acid mediated adenoviral transduction
06/28/2007US20070148733 Yeast expression vectors for production of ITF
06/28/2007US20070148732 Novel enzymes
06/28/2007US20070148731 Expression control sequence cassette; a nucleotide sequence of a lac operator sequence to which a lacI repressor protein specifically binds a mutated lac; modification of the nucleotide sequence within a T5 promoter/lac operator expression control sequence provides a stable promoter/operator
06/28/2007US20070148730 Superactive cellulase formulation using cellobiohydrolase-1 from penicillium funiculosum
06/28/2007US20070148729 Methods for increasing neisseria protein expression and compositions thereof
06/28/2007US20070148728 Recombinantly and transgenically produced glycoproteins; efficient method for enzymatically synthesizing glycoconjugates having the desired fucoylated oligosaccharide moieties
06/28/2007US20070148715 Method for detecting transient ligand interactions
06/28/2007US20070148708 Protease inhibitor conjugates and antibodies useful in immunoassay
06/28/2007US20070148692 KCNQ potassium channels and methods of modulating same
06/28/2007US20070148686 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof
06/28/2007US20070148680 Detection of disease related genes
06/28/2007US20070148673 To generate transgenic, non-human plants or animals or site specific gene modifications in cell lines; fluorescent proteins high through-put screening assays; use as biosensors in prokaryotic and eukaryotic cells, fluorescence activated cell sorting applications, as markers following injection into cells
06/28/2007US20070148669 comprising N-{3-(hydroxyaminocarbonyl)-1-oxo-(2R)-benzylpropyl}-Ile-Leu-OH as in catalytic domain of modified tumor necrosis factor-alpha converting enzyme; less susceptible to autoproteolysis; drug design; host cells; computers